Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2592906 | Regulatory Toxicology and Pharmacology | 2008 | 12 Pages |
Abstract
An increased Leydig cell tumor (LCT) incidence has been reported in a study of Sprague-Dawley (SD) rats exposed via gavage to 1000 (but not 250) mg/kg day MTBE; it is unclear, however, if this finding was indeed dose-related or due to the statistical analyses not having adequately accounted for the increased survival rate in the high-dose animals and/or for multiple statistical comparisons. To address this question, we conducted Hoel-Walburg and Poly-3 analyses, using p-values of 0.01 for pair-wise comparisons and 0.005 for trend tests of common tumors. We found that MTBE does not cause a statistically significant increase in LCTs in SD rats when survival is appropriately taken into account. In addition, the original study reported some overall survival data, but did not specify which rats had LCTs. This led us to conduct separate Poly-3 analyses for the most extreme scenarios of survival age and tumor incidence to provide an illustrative example of approaches for analyzing the impact of survival rates on tumor findings in the absence of animal-specific survival data. We found this method to provide results similar to analyses using the actual data, suggesting that it can be used when full survival data are not available.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Julie E. Goodman, David Gaylor, Leslie A. Beyer, Lorenz R. Rhomberg, Barbara D. Beck,